BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18473789)

  • 21. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.
    Casalino E; Wolff M; Ravaud P; Choquet C; Bruneel F; Regnier B
    AIDS; 2004 Jul; 18(10):1429-33. PubMed ID: 15199319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morbidity and mortality in HIV-infected children on antiretroviral therapy in Togo.
    Mouhari-Touré A; Mahamadou G; Kombate K; Akakpo AS; Teclessou JN; Singo A; Pitché P
    Med Sante Trop; 2018 Feb; 28(1):54-60. PubMed ID: 29616646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.
    Jain MK; Skiest DJ; Cloud JW; Jain CL; Burns D; Berggren RE
    Clin Infect Dis; 2003 Apr; 36(8):1030-8. PubMed ID: 12684916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.
    Gutierrez F; Padilla S; Masiá M; Iribarren JA; Moreno S; Viciana P; Muñoz L; Gómez Sirvent JL; Vidal F; López-Aldeguer J; Blanco JR; Leal M; Rodríguez-Arenas MA; Perez Hoyos S;
    PLoS One; 2006 Dec; 1(1):e89. PubMed ID: 17183720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
    Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjananit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Feb; 44(4):599-604. PubMed ID: 17243067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends and characteristics of all-cause mortality among HIV-infected inpatients during the HAART era (2006-2015) in Shanghai, China.
    Ji Y; Wang Z; Shen J; Chen J; Yang J; Qi T; Song W; Tang Y; Liu L; Shen Y; Zhang R; Lu H
    Biosci Trends; 2017 Mar; 11(1):62-68. PubMed ID: 28132999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers.
    Sabin CA; Smith CJ; Youle M; Lampe FC; Bell DR; Puradiredja D; Lipman MC; Bhagani S; Phillips AN; Johnson MA
    AIDS; 2006 Jan; 20(1):67-71. PubMed ID: 16327321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu Teaching Hospital.
    Saavedra A; Campinha-Bacote N; Hajjar M; Kenu E; Gillani FS; Obo-Akwa A; Lartey M; Kwara A
    Pan Afr Med J; 2017; 27():48. PubMed ID: 28819470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia.
    Ebissa G; Deyessa N; Biadgilign S
    AIDS Care; 2015; 27(6):723-30. PubMed ID: 25599414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.
    Chan KC; Wong KH; Lee SS
    HIV Med; 2006 Apr; 7(3):186-92. PubMed ID: 16494633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.
    Kassa A; Teka A; Shewaamare A; Jerene D
    Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):363-70. PubMed ID: 22521216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morbidity and mortality in ageing HIV-infected haemophilia patients.
    Fransen van de Putte DE; Fischer K; Roosendaal G; Hoepelman AI; Mauser-Bunschoten EP
    Haemophilia; 2013 Jan; 19(1):141-9. PubMed ID: 22830609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In-hospital mortality in HIV-infected patients: 10 years after the implementation of universal access to HAART in Mexico].
    Martín-Onraet A; Piñeirua-Menéndez A; Perales-Martínez D; Ortega-Pérez R; Barrera-García A; Sierra-Madero J; Volkow-Fernández P
    Salud Publica Mex; 2015; 57 Suppl 2():s163-70. PubMed ID: 26545132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in the spectrum of morbidity and mortality in hospital admissions of HIV infected patients during the HAART era].
    Escolano Hortelano CM; Ramos Rincón JM; Gutiérrez Rodero F; Masiá Canuto M; Hernández Aguado I; Benito Santaleocadia C; Padilla Urrea S; Martín-Hidalgo A
    Med Clin (Barc); 2004 Jan; 122(1):1-5. PubMed ID: 14733866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sex specific mortality in HIV/AIDS patients receiving antiretroviral therapy and risk factors in Xinjiang Uygur autonomous region].
    Ni M; Chen X; Ma Y; Hu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Sep; 36(9):971-5. PubMed ID: 26814865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
    Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
    JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality trends of HIV-infected patients after the introduction of highly active antiretroviral therapy: analysis of a cohort of 3,322 HIV-infected persons.
    Mayor AM; Gómez MA; Ríos-Oliveras E; Hunter-Mellado RF
    Ethn Dis; 2005; 15(4 Suppl 5):S5-57-62. PubMed ID: 16312941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
    Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
    J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.